Sensorion’s Oral SENS-401 prevented cisplatin-induced hearing loss (Audiology Worldnews)

Date: 
06 October, 2017
Credit: 
Audiology Worldnews
Category: 
SAC News
Audiology
Public

“In regulatory news reported by Business Insider, Sensorion, a biotech company developing novel treatments for inner ear diseases, recently published findings showing that…” Continue reading.